688266.SH
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 87.79
−6.61%Leverage
- Debt / equity
- 0.55x
- Net debt / equity
- -0.75x
- Debt / assets
- 0.25x
- Debt / EBITDA
- -7.78x
- Net debt / EBITDA
- 10.69x
Liquidity & coverage
- Current ratio
- 2.36x
- Quick ratio
- 2.23x
- Cash ratio
- —
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- CNY 1.8B
Cash & dividend
- FCF / debt
- 0.68x
- Cash flow / debt
- 0.87x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026